Engels K - Search Results

1

NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.

Engels K, Knauer SK, Loibl S, Fetz V, Harter P, Schweitzer A, Fisseler-Eckhoff A, Kommoss F, Hanker L, Nekljudova V, Hermanns I, Kleinert H, Mann W, du Bois A, Stauber RH. Engels K, et al. Cancer Res. 2008 Jul 1;68(13):5159-66. doi: 10.1158/0008-5472.CAN-08-0406. Cancer Res. 2008. PMID: 18593915

2

Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.

Fetz V, Bier C, Habtemichael N, Schuon R, Schweitzer A, Kunkel M, Engels K, Kovács AF, Schneider S, Mann W, Stauber RH, Knauer SK. Fetz V, et al. Among authors: engels k. Int J Cancer. 2009 May 1;124(9):2033-41. doi: 10.1002/ijc.24182. Int J Cancer. 2009. PMID: 19130609 Free article.

3

Nuclear export is essential for the tumor-promoting activity of survivin.

Knauer SK, Krämer OH, Knösel T, Engels K, Rödel F, Kovács AF, Dietmaier W, Klein-Hitpass L, Habtemichael N, Schweitzer A, Brieger J, Rödel C, Mann W, Petersen I, Heinzel T, Stauber RH. Knauer SK, et al. Among authors: engels k. FASEB J. 2007 Jan;21(1):207-16. doi: 10.1096/fj.06-5741com. Epub 2006 Nov 10. FASEB J. 2007. PMID: 17099069

4

VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.

Engels K, du Bois A, Harter P, Fisseler-Eckhoff A, Kommoss F, Stauber R, Kaufmann M, Nekljudova V, Loibl S. Engels K, et al. J Clin Pathol. 2009 May;62(5):448-54. doi: 10.1136/jcp.2008.063859. Epub 2009 Jan 6. J Clin Pathol. 2009. PMID: 19126566

5

Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal.

Stauber RH, Rabenhorst U, Rekik A, Engels K, Bier C, Knauer SK. Stauber RH, et al. Among authors: engels k. Traffic. 2006 Nov;7(11):1461-72. doi: 10.1111/j.1600-0854.2006.00486.x. Epub 2006 Sep 19. Traffic. 2006. PMID: 16984408 Free article.

6

The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer.

Seil I, Frei C, Sültmann H, Knauer SK, Engels K, Jäger E, Zatloukal K, Pfreundschuh M, Knuth A, Tseng-Chen Y, Jungbluth AA, Stauber RH, Jäger D. Seil I, et al. Among authors: engels k. Int J Cancer. 2007 Jun 15;120(12):2635-42. doi: 10.1002/ijc.22620. Int J Cancer. 2007. PMID: 17330232 Free article.

7

Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.

Engels K, Knauer SK, Metzler D, Simf C, Struschka O, Bier C, Mann W, Kovács AF, Stauber RH. Engels K, et al. J Pathol. 2007 Apr;211(5):532-540. doi: 10.1002/path.2134. J Pathol. 2007. PMID: 17334981

8

The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.

Knauer SK, Bier C, Schlag P, Fritzmann J, Dietmaier W, Rödel F, Klein-Hitpass L, Kovács AF, Döring C, Hansmann ML, Hofmann WK, Kunkel M, Brochhausen C, Engels K, Lippert BM, Mann W, Stauber RH. Knauer SK, et al. Among authors: engels k. Cell Cycle. 2007 Jun 15;6(12):1502-9. Epub 2007 Apr 15. Cell Cycle. 2007. PMID: 17582222

9

A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial.

Karn T, Meissner T, Weber KE, Solbach C, Denkert C, Engels K, Fasching PA, Sinn BV, Schrader I, Budczies J, Marmé F, Müller V, Holtrich U, Gerber B, Schem C, Young BM, Hanusch C, Stickeler E, Huober J, van Mackelenbergh M, Leyland-Jones B, Fehm T, Nekljudova V, Untch M, Loibl S. Karn T, et al. Among authors: engels k. Clin Cancer Res. 2020 Apr 15;26(8):1896-1904. doi: 10.1158/1078-0432.CCR-19-1954. Epub 2020 Jan 13. Clin Cancer Res. 2020. PMID: 31932495 Clinical Trial.

10

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.

Leichsenring J, Vladimirova V, Solbach C, Karn T, Ataseven B, Sinn BV, Barinoff J, Müller V, Blohmer JU, Schem C, Engels K, Marmé F, Fisseler-Eckhoff A, Fasching PA, Stickeler E, van Mackelenbergh M, Denkert C, Stenzinger A, Loibl S, Gröschel S. Leichsenring J, et al. Among authors: engels k. BMC Cancer. 2022 Oct 5;22(1):1040. doi: 10.1186/s12885-022-10109-1. BMC Cancer. 2022. PMID: 36195836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page